Space Station Study Investigates How Pneumonia Bacteria Affect the Heart

Expedition 74 astronauts aboard the International Space Station (ISS) are conducting the MVP Cell-09 investigation, a groundbreaking study examining how Streptococcus pneumoniae bacteria impact heart tissue.

"By exacerbating the infection, we anticipate clear separation of the infection and control groups, making it easier to identify subtle factors that promote bacterial virulence."
— Dr. Palaniappan Sethu, University of Alabama at Birmingham

The Research Approach

Researchers are using stem cell-derived heart tissues exposed to bacteria in microgravity to observe cellular responses. The unique environment of the ISS allows scientists to magnify infection effects that are often too subtle to detect in Earth-based laboratories.

Why This Matters

Community-acquired pneumonia (CAP), primarily caused by Streptococcus pneumoniae, leads to millions of deaths each year worldwide. The connection between pneumonia and heart disease is especially concerning:

• Over 25% of adults hospitalized for CAP develop heart disease
• Survivors face increased long-term risk even after full recovery

Key Scientific Goals

The study aims to:

• Identify factors that increase bacterial virulence in space
• Understand how drug resistance develops in microgravity
• Reveal new treatment targets for pneumonia-related heart complications

Implications Beyond Earth

"Addressing these questions is essential for ensuring human health during long duration space travel and for enabling sustainable habitation beyond Earth."
— Dr. Carlos J. Orihuela, University of Alabama at Birmingham

Dr. Orihuela further emphasized that the experiments are expected to generate new insights into how space-specific factors influence disease progression, knowledge that will be critical as humanity prepares for extended missions and potential off-world settlements.